Medicare Enrolled

Dr. Gary Gilcrease, MD

Family Medicine · Buda, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
155 CIMARRON PARK LOOP, Buda, TX 78610
5122959300
In practice since 2006 (19 years)
NPI: 1427090893 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gilcrease from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gilcrease? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gilcrease

Dr. Gary Gilcrease is a family medicine in Buda, TX, with 19 years in practice. Based on federal Medicare data, Dr. Gilcrease performed 731 Medicare services across 589 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gilcrease received a total of $15,700 from 60 pharmaceutical and/or device companies across 953 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gilcrease is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 37% volume in TX$ $15,700 industry payments

Medicare Practice Summary

Medicare Utilization ↗
731
Medicare services
Top 37% in TX for family medicine
589
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)361$69$330
Annual wellness visit, follow-up144$125$357
Urinalysis, manual136$3$10
Office visit, established patient (20-29 min)57$46$222
Annual depression screening18$18$56
Electrocardiogram (EKG), 12-lead15$7$52
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,700
Total received (2018-2024)
Avg $2,243/year across 7 years
Top 2% in TX for family medicine
60
Companies
953
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,942 (88.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,443 (9.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$315 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,230
2023
$1,367
2022
$2,284
2021
$2,299
2020
$1,541
2019
$2,210
2018
$3,769

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,856
Novo Nordisk Inc
$1,742
Lilly USA, LLC
$1,376
AstraZeneca Pharmaceuticals LP
$1,246
Boehringer Ingelheim Pharmaceuticals, Inc.
$801
GlaxoSmithKline, LLC.
$774
Amgen Inc.
$743
Amarin Pharma Inc.
$689
Takeda Pharmaceuticals U.S.A., Inc.
$679
ABBVIE INC.
$631
Corcept Therapeutics
$549
Astellas Pharma US Inc
$533
PFIZER INC.
$359
AbbVie Inc.
$354
Mylan Specialty L.P.
$318
SANOFI-AVENTIS U.S. LLC
$302
Allergan Inc.
$300
Janssen Pharmaceuticals, Inc
$268
Mannkind Corporation
$244
Allergan, Inc.
$226
Otsuka America Pharmaceutical, Inc.
$165
Abbott Laboratories
$136
Shire North American Group Inc
$135
SHIELD THERAPEUTICS INC
$116
MannKind Corporation
$68
Biohaven Pharmaceutical Holding Company Ltd.
$65
Bayer HealthCare Pharmaceuticals Inc.
$64
Kowa Pharmaceuticals America, Inc.
$62
Novartis Pharmaceuticals Corporation
$61
Teva Pharmaceuticals USA, Inc.
$59
Assertio Therapeutics, Inc.
$53
Dexcom, Inc.
$47
Exact Sciences Corporation
$44
Biohaven Pharmaceuticals, Inc.
$41
Phathom Pharmaceuticals, Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$39
Renalytix AI, Inc.
$37
Esperion Therapeutics, Inc.
$37
ConvaTec Inc.
$34
Medtronic, Inc.
$33
Antares Pharma, Inc.
$31
Horizon Therapeutics plc
$30
Supernus Pharmaceuticals, Inc.
$27
Azurity Pharmaceuticals, Inc.
$22
Adlon Therapeutics L.P.
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
MEDICOMP INC
$19
Xeris Pharmaceuticals, Inc.
$19
Nuvectra Corporation
$18
Eisai Inc.
$18
Alkermes, Inc.
$18
Promius Pharma LLC
$17
Phadia US Inc.
$17
IRONSHORE PHARMACEUTICALS INC.
$15
Radius Health, Inc.
$15
Exeltis, USA Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Itamar Medical Inc
$12
Lundbeck LLC
$12
Purdue Pharma L.P.
$11
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AFREZZA · AIRSUPRA · AJOVY · AMBULATORY CARDIAC MONITOR · ANORO · AREXVY · Aimovig · Algovita · Amitiza · BASAGLAR · BREO · BREZTRI · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CYCLOSET · Cambia · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · Gralise · HORIZANT · INNOVAMATRIX AC · INVOKANA · ImmunoCAP · JARDIANCE · JORNAY PM · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LINZESS · LYRICA · Livalo · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · NAMZARIC · NEXLETOL · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PENNSAID · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · Qelbree · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SLYND · SOLIQUA · SOLIQUA 100/33 · SUNOSI · SYMBICORT · SYMPROIC · SYNJARDY · SYNTHROID · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VANTA ADAPTIVESTIM · VIVITROL · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · WatchPAT · XARELTO · XIFAXAN · XIFIXAN · YUPELRI · Yupelri · ZORYVE · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.

Equivalent to $2,148 per 100 Medicare services performed
Looking for a family medicine in Buda?
Compare family medicines in the Buda area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
589
Per 100K population
229.7
County median income
$85,827
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER - BUDA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gilcrease is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gilcrease experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gilcrease performed 361 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gilcrease receive payments from pharmaceutical companies?
Yes. Dr. Gilcrease received a total of $15,700 from 60 companies across 953 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gilcrease's costs compare to other family medicines in Buda?
Dr. Gilcrease's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gilcrease) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →